Drug
Benralizumab
Benralizumab: highest development phase Phase 3, developed by AstraZeneca. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Benralizumab NCT04157348 | Phase 3 | Eosinophilic Granulomatous Vasculitis |
| Benralizumab NCT03557307 | Phase 3 | Asthma |
| Benralizumab NCT07444567 | Phase 3 | Asthma |
Latest
No recent events.
Follow Benralizumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.